Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes von Aguirre, Luis E., Al Ali, Najla, Sallman, David A., Ball, Somedeb, Jain, Akriti G., Chan, Onyee, Tinsley-Vance, Sara M., Kuykendall, Andrew, Sweet, Kendra, Lancet, Jeffrey E., Padron, Eric, Komrokji, Rami S.

Volltext

Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients von Ball, Somedeb, Aguirre, Luis E., Jain, Akriti G., Ali, Najla Al, Tinsley, Sara M., Chan, Onyee, Kuykendall, Andrew T., Sweet, Kendra, Lancet, Jeffrey E., Sallman, David A., Hussaini, Mohammad Omar, Padron, Eric, Komrokji, Rami S.

Volltext

Practical Management of Lenalidomide-Related Rash von Tinsley, Sara M, Kurtin, Sandra E, Ridgeway, Jean A

Volltext

Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration von Park, Margaret A, Whelan, Christopher J, Ahmed, Sabeen, Boeringer, Tabitha, Brown, Joel, Crowder, Sylvia L, Gage, Kenneth, Gregg, Christopher, Jeong, Daniel K, Jim, Heather S L, Judge, Andrew R, Mason, Tina M, Parker, Nathan, Pillai, Smitha, Qayyum, Aliya, Rajasekhara, Sahana, Rasool, Ghulam, Tinsley, Sara M, Schabath, Matthew B, Stewart, Paul, West, Jeffrey, McDonald, Patricia, Permuth, Jennifer B

Volltext

An integrative review of cancer-related cachexia and sarcopenia: A different focus in malignant hematology von Tinsley-Vance, Sara M., Mason, Tina M., Komrokji, Rami S.

Volltext

Treatment Choices: A Quality of Life Comparison in Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome von Tinsley, Sara M., Sutton, Steven K., Thapa, Ram, Lancet, Jeffrey, McMillan, Susan C.

Volltext

Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in Oncology von Tinsley, Sara M, Grande, Carolyn, Olson, Karin, Plato, Leah, Jacobs, Ira

Volltext

Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia von Tinsley, Sara M

Volltext

Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia von Tinsley-Vance, Sara M

Volltext

Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes von Tinsley-Vance, Sara M, Ali, Najla Al, Ball, Somedeb, Aguirre, Luis E, Jain, Akriti G, Hussaini, Mohammad Omar, Chan, Onyee, Kuykendall, Andrew, Sweet, Kendra, Lancet, Jeffrey, Padron, Eric, Sallman, David A, Komrokji, Rami S

Volltext

Predictors of Quality of Life for High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia von Tinsley, Sara M., MS, ARNP, AOCN, Komrokji, Rami, MD, List, Alan F., MD

Volltext

Lived experiences of lymphoma patients with sexual dysfunction and related sexual distress during cancer treatment von Durosier Mertilus, Dorothie S., Rodriguez, Carmen S., Lengacher, Cecile A., Donovan, Kristine A., Sokol, Lubomir, Tinsley-Vance, Sara M., Szalacha, Laura A.

Volltext

Caring for Patients with Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitor (TKI) Therapy in an Era of Evolving Treatment Goals von Nodzon, Lisa A., Tinsley, Sara M.

Volltext

Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in Therapy-Related Myelodysplastic Syndromes von Aguirre, Luis E., Al Ali, Najla, Ball, Somedeb, Singh, Avani M, Jain, Akriti G, Chan, Onyee, Schwabkey, Zaker I., Tinsley-Vance, Sara M, Kuykendall, Andrew, Sweet, Kendra, Lancet, Jeffrey E., Padron, Eric, Sallman, David A., Komrokji, Rami S.

Volltext

A Product of "Clash of Titans" or True Reflection of Disease Biology? Validation of 2022 WHO and ICC Classifications in a Large Dataset of Patients with Myelodysplastic Syndrome von Ball, Somedeb, Singh, Avani M, Ali, Najla Al, Aguirre, Luis E., Jain, Akriti G, Schwabkey, Zaker I., Tinsley-Vance, Sara M, Chan, Onyee, Kuykendall, Andrew, Sweet, Kendra, Lancet, Jeffrey E., Padron, Eric, Sallman, David A., Komrokji, Rami S.

Volltext

Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in Hypoplastic Myelodysplastic Syndromes von Aguirre, Luis E., Al Ali, Najla, Ball, Somedeb, Singh, Avani M, Jain, Akriti G, Chan, Onyee, Schwabkey, Zaker I., Tinsley-Vance, Sara M, Kuykendall, Andrew, Sweet, Kendra, Lancet, Jeffrey E., Padron, Eric, Sallman, David A., Komrokji, Rami S.

Volltext

Validation of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model for Myelodysplastic Syndromes von Aguirre, Luis E., Al Ali, Najla, Ball, Somedeb, Singh, Avani M, Jain, Akriti G, Chan, Onyee, Schwabkey, Zaker I., Tinsley-Vance, Sara M, Kuykendall, Andrew, Sweet, Kendra, Lancet, Jeffrey E., Padron, Eric, Sallman, David A., Komrokji, Rami S.

Volltext

Hypoplastic MDS: Validation of the New World Health Organization 2022 Proposal von Schwabkey, Zaker I., Azem, Amin, Al Ali, Najla, Ball, Somedeb, Aguirre, Luis E., Jain, Akriti G, Singh, Avani M, Tinsley-Vance, Sara M, Chan, Onyee, Lancet, Jeffrey E., Sweet, Kendra, Kuykendall, Andrew, Padron, Eric, Sallman, David A., Komrokji, Rami S.

Volltext

What Is the Impact on Quality of Life of Various Treatments in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome? Rethinking the Goals von Tinsley, Sara M., Small, Brent J, Lancet, Jeffrey E, McMillan, Susan C, Komrokji, Rami S., Padron, Eric, Zuckerman, Kenneth S., List, Alan F.

Volltext

Efficacy and Safety of Ruxolitinib for Treatment of Symptomatic Chronic Myelomonocytic Leukemia (CMML): Results of a Multicenter Phase II Clinical Trial von Padron, Eric, Tinsley-Vance, Sara M, DeZern, Amy E., Carraway, Hetty E., Luskin, Marlise R., Roboz, Gail J., Chan, Onyee, Horton, Meagan, Gerds, Aaron T., Sallman, David A., Kuykendall, Andrew, Steensma, David, Balasis, Maria E, Lancet, Jeffrey E., Sekeres, Mikkael A., Komrokji, Rami S.

Volltext